Start:
August 2012
End:
May 2018
Enrollment:
120
The purpose of this study is to determine the value of arterial spin labeling magnetic resonance imaging (ASL MRI), a measure of blood flow to the brain, in finding the cause of cognitive decline in people with mild cognitive impairment (MCI). Investigators will also compare ASL MRI to existing measures, in particular positron emission tomography (PET).
Minimum Age: 55 Years
Maximum Age: 89 Years
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Lead: University of Pennsylvania
Collaborator Sponsor
Source: ClinicalTrials.gov ID: NCT01727622
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health